AngioDynamics(ANGO)
$12.42+0.35 (+2.90%)
ANGO
AngioDynamics financials statements
$12.42
At close:+0.35 (+2.90%)
Want to see ANGO full AI Analyst Report?
AngioDynamics (ANGO) Ratios
533 Followers
AngioDynamics Ratios
ANGO's free cash flow for Q1 2027 was $-15.71M. For the 2027 fiscal year, ANGO's free cash flow was decreased by $-379.00K and operating cash flow was $-15.33M. See a summary of the company’s cash flow.
| Ratios | May 26 | May 25 | May 24 | May 23 | May 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.19 | 2.21 | 2.12 | 1.95 | 1.93 |
| Quick Ratio | 1.49 | 1.40 | 1.46 | 1.29 | 1.24 |
| Cash Ratio | 0.72 | 0.73 | 0.83 | 0.53 | 0.39 |
| Solvency Ratio | -0.14 | -0.08 | -1.40 | -0.14 | 0.02 |
| Operating Cash Flow Ratio | 0.04 | -0.13 | -0.31 | 0.00 | -0.10 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -25.32 | -5.96 | 0.01 | -0.82 |
| Net Current Asset Value | $ 67.06M | $ 71.15M | $ 81.17M | $ 9.20M | $ 15.08M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.04 | 0.01 | 0.12 | 0.06 |
| Debt-to-Equity Ratio | 0.00 | 0.06 | 0.02 | 0.17 | 0.08 |
| Debt-to-Capital Ratio | 0.00 | 0.05 | 0.02 | 0.15 | 0.07 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.03 | 0.00 | 0.12 | 0.06 |
| Financial Leverage Ratio | 1.56 | 1.53 | 1.55 | 1.41 | 1.30 |
| Debt Service Coverage Ratio | 0.15 | 4.44 | 0.24 | 0.81 | 1.53 |
| Interest Coverage Ratio | -133.54 | 0.00 | 0.00 | -18.94 | -41.38 |
| Debt to Market Cap | 0.00 | 0.01 | 0.02 | 0.17 | 0.04 |
| Interest Debt Per Share | 0.01 | 0.25 | 0.12 | 1.70 | 0.88 |
| Net Debt to EBITDA | -110.38 | -26.32 | 11.63 | 1.64 | 0.45 |
| Profitability Margins | |||||
| Gross Profit Margin | 54.62% | 53.92% | 50.90% | 51.44% | 52.41% |
| EBIT Margin | -7.02% | -8.23% | -11.14% | -5.51% | -5.76% |
| EBITDA Margin | 0.15% | 0.59% | -2.02% | 3.60% | 3.52% |
| Operating Profit Margin | -12.47% | -13.66% | -63.32% | -15.11% | -9.00% |
| Pretax Profit Margin | -11.34% | -11.63% | -63.06% | -16.07% | -9.47% |
| Net Profit Margin | -11.48% | -11.62% | -60.66% | -15.48% | -8.40% |
| Continuous Operations Profit Margin | -11.48% | -11.62% | -60.66% | -15.48% | -8.40% |
| Net Income Per EBT | 101.22% | 99.89% | 96.20% | 96.34% | 88.64% |
| EBT Per EBIT | 90.92% | 85.18% | 99.59% | 106.36% | 105.19% |
| Return on Assets (ROA) | -13.75% | -12.13% | -58.03% | -9.85% | -4.80% |
| Return on Equity (ROE) | -21.51% | -18.58% | -89.67% | -13.86% | -6.25% |
| Return on Capital Employed (ROCE) | -20.75% | -19.59% | -84.95% | -11.40% | -5.95% |
| Return on Invested Capital (ROIC) | -20.75% | -19.36% | -80.05% | -10.64% | -5.18% |
| Return on Tangible Assets | -18.38% | -16.11% | -76.72% | -20.00% | -13.32% |
| Earnings Yield | -8.11% | -8.13% | -72.71% | -14.04% | -3.47% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.63 | 6.78 | 6.08 | 6.41 | 5.60 |
| Payables Turnover | 4.61 | 4.05 | 3.95 | 4.07 | 5.37 |
| Inventory Turnover | 2.77 | 2.17 | 2.46 | 2.97 | 2.93 |
| Fixed Asset Turnover | 11.82 | 9.06 | 8.52 | 7.63 | 7.03 |
| Asset Turnover | 1.20 | 1.04 | 0.96 | 0.64 | 0.57 |
| Working Capital Turnover Ratio | 3.54 | 3.01 | 3.34 | 4.56 | 4.15 |
| Cash Conversion Cycle | 107.66 | 131.59 | 115.99 | 89.93 | 121.84 |
| Days of Sales Outstanding | 55.09 | 53.83 | 60.06 | 56.92 | 65.21 |
| Days of Inventory Outstanding | 131.74 | 167.90 | 148.27 | 122.75 | 124.65 |
| Days of Payables Outstanding | 79.17 | 90.15 | 92.34 | 89.74 | 68.03 |
| Operating Cycle | 186.83 | 221.74 | 208.34 | 179.67 | 189.86 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.07 | -0.25 | -0.70 | 0.00 | -0.18 |
| Free Cash Flow Per Share | 0.01 | -0.36 | -0.84 | -0.11 | -0.29 |
| Dividend Paid and CapEx Coverage Ratio | 1.20 | -2.27 | -4.88 | 0.02 | -1.67 |
| Capital Expenditure Coverage Ratio | 1.20 | -2.27 | -4.88 | 0.02 | -1.67 |
| Operating Cash Flow Coverage Ratio | 0.00 | -1.00 | -5.96 | 0.00 | -0.21 |
| Operating Cash Flow to Sales Ratio | 0.01 | -0.03 | -0.09 | 0.00 | -0.02 |
| Free Cash Flow Yield | 0.11% | -3.49% | -13.38% | -1.14% | -1.50% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -12.40 | -12.29 | -1.38 | -7.12 | -28.85 |
| Price-to-Sales (P/S) Ratio | 1.42 | 1.43 | 0.83 | 1.10 | 2.42 |
| Price-to-Book (P/B) Ratio | 2.65 | 2.28 | 1.23 | 0.99 | 1.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 891.83 | -28.65 | -7.47 | -87.39 | -66.64 |
| Price-to-Operating Cash Flow Ratio | 146.67 | -41.28 | -9.00 | 4788.26 | -106.44 |
| Price-to-Earnings Growth (PEG) Ratio | -2.06 | 0.15 | -0.01 | -0.07 | 1.69 |
| Enterprise Value Multiple | 818.00 | 214.21 | -29.72 | 32.27 | 69.23 |
| Enterprise Value | 399.18M | 372.29M | 182.21M | 393.44M | 770.71M |
| EV to EBITDA | 818.00 | 214.21 | -29.72 | 32.27 | 69.23 |
| EV to Sales | 1.25 | 1.27 | 0.60 | 1.16 | 2.44 |
| EV to Free Cash Flow | 785.80 | -25.51 | -5.37 | -92.06 | -67.07 |
| EV to Operating Cash Flow | 129.23 | -36.76 | -6.47 | 5044.14 | -107.13 |
| Tangible Book Value Per Share | 2.50 | 2.78 | 3.19 | 2.73 | 1.82 |
| Shareholders’ Equity Per Share | 4.11 | 4.46 | 5.12 | 9.58 | 10.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.00 | 0.04 | 0.04 | 0.11 |
| Revenue Per Share | 7.71 | 7.14 | 7.56 | 8.58 | 8.11 |
| Net Income Per Share | -0.88 | -0.83 | -4.59 | -1.33 | -0.68 |
| Tax Burden | 1.01 | 1.00 | 0.96 | 0.96 | 0.89 |
| Interest Burden | 1.62 | 1.41 | 5.66 | 2.91 | 1.64 |
| Research & Development to Revenue | 0.09 | 0.09 | 0.10 | 0.09 | 0.10 |
| SG&A to Revenue | 0.49 | 0.50 | 0.14 | 0.12 | 0.12 |
| Stock-Based Compensation to Revenue | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 |
| Income Quality | -0.08 | 0.30 | 0.15 | -0.00 | 0.27 |
Currency in USD
